Uveal melanoma (UM) is the most common primary intraocular malignancy affecting adults.
Despite successful local treatment of the primary tumour, metastatic disease develops in up …

Background: The detection of circulating tumor cells (CTC) in patients with melanoma
represents an appealing prognostic tool, but no consensus exists on this topic. We aimed to …

Background A limitation of positive selection strategies to enrich for circulating tumor cells
(CTCs) is that there might be CTCs with insufficient expression of the surface target marker …

The worldwide incidence of malignant melanoma has been increasing during the past
decade and is a public health concern because this disease accounts for up to 90% of …

Background: Enumeration of circulating tumor cells (CTCs) may be valuable for lung cancer
treatment and monitoring cancer patient relapse. In the present study we report clinical …

Purpose: Current lung cancer staging and prognosis methods are based on imaging
methods, which may not be sensitive enough for early and accurate detection of metastasis …

Purpose: Nodal micrometastasis and circulating tumor cells detected by multimarker
quantitative real-time reverse transcription-PCR (qRT-PCR) may have prognostic …

Simple Summary Uveal melanoma is an aggressive cancer that begins in the eye, but often
spreads to distant organs when tumor cells enter the blood. Disease spreads in nearly half …

Purpose: To develop a molecular tool to detect circulating tumor–derived DNA (ctDNA) in
the plasma from patients with uveal melanoma as a marker of tumor burden and monitor …

In the era of precision oncology, major strides are being made to use individual tumor
information for clinical decision-making. Differing from traditional biopsy methods, the …